|
Re: Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
4
|
Resverlogix Corp.
|
Mar 31, 2020 10:50AM
|
|
Re: Losing exclusivity on Aberatirone may not be all that bad for JNJ or ZEL
|
4
|
Zenith Epigenetics
|
Nov 22, 2018 05:53PM
|
|
Notice of Annual and Special Meeting on September 30th 2015
|
4
|
Resverlogix Corp.
|
Jul 20, 2015 05:33PM
|
|
MD&A
|
4
|
Resverlogix Corp.
|
Mar 12, 2019 02:22PM
|
|
Re: Goodbye March, Hello April
|
4
|
Resverlogix Corp.
|
Mar 26, 2019 08:25PM
|
|
EASD 2019 Sept 16-20, 2019
|
4
|
Resverlogix Corp.
|
Jul 18, 2019 04:18PM
|
|
Re: New content on Publications page of RVX website
|
4
|
Resverlogix Corp.
|
Jun 09, 2016 02:13PM
|
|
Re: What happens when the database is locked?
|
4
|
Resverlogix Corp.
|
Sep 01, 2019 04:03PM
|
|
Re: The 34.4 million
|
4
|
Zenith Epigenetics
|
Dec 07, 2015 01:27PM
|
|
Revamped website
|
4
|
Resverlogix Corp.
|
Jan 05, 2019 11:53AM
|
|
Resverlogix Intends to Pursue U.S. Listing
|
4
|
Resverlogix Corp.
|
Jul 31, 2018 06:21PM
|
|
Resverlogix Announces $26 Million Private Placement
|
4
|
Resverlogix Corp.
|
Aug 30, 2018 08:18AM
|
|
Re: Bio Europe slide deck
|
4
|
Zenith Epigenetics
|
Dec 06, 2018 09:26AM
|
|
Re: Zenith Announces Issuance of Patent for ZEN-3694 and Presentation Details at BIO International Convention
|
4
|
Zenith Epigenetics
|
Jun 05, 2017 12:01PM
|
|
COLCORONA trial: Colchicine reduces the risk of COVID-19-related complications
|
4
|
Resverlogix Corp.
|
Jan 23, 2021 11:06AM
|
|
Re: What happens when the database is locked?
|
4
|
Resverlogix Corp.
|
Sep 01, 2019 06:40PM
|
|
Re: Zenith new VP
|
4
|
Zenith Epigenetics
|
Aug 03, 2017 12:57PM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
4
|
Resverlogix Corp.
|
Jun 30, 2019 02:53PM
|
|
Re: New Share Price Contest update to Oct 12th
|
4
|
Resverlogix Corp.
|
Oct 13, 2019 02:03PM
|
|
Re: Abstract up
|
4
|
Resverlogix Corp.
|
Mar 17, 2020 11:51PM
|
